BIOR insider filings
BIORA THERAPEUTICS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-12-16. Screen BIOR transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BIOR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — BIORA THERAPEUTICS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-12-16 | 4 | Athyrium Opportunities III Co-Invest 1 LP — Director, 10% owner Athyrium Opportunities III Acquisition LP — Director, 10% owner Athyrium Opportunities III Acquisition 2 LP — Director, 10% owner Athyrium Opportunities 2020 LP — Director, 10% owner Ferrell Jeffrey — Director, 10% owner Athyrium Opportunities Associates Co-Invest LLC — Director, 10% owner Athyrium Funds GP Holdings LLC — Director, 10% owner Athyrium Opportunities Associates III LP — Director, 10% owner Athyrium Opportunities Associates III GP LLC — Director, 10% owner | Grant/award (A) | EDGAR |
| 2024-08-16 | 4 | MOHANTY ADITYA P. — Chief Executive Officer, Director | Tax withholding (F): 70,883 @ $0.67 | EDGAR |
| 2024-08-16 | 4 | dEsparbes Eric — Chief Financial Officer | Tax withholding (F): 27,830 @ $0.67 | EDGAR |
| 2024-08-16 | 4 | NEUMANN CLARKE — See Remarks | Tax withholding (F): 26,629 @ $0.67 | EDGAR |
| 2024-08-14 | 4 | Athyrium Opportunities III Co-Invest 1 LP — Director, 10% owner Athyrium Opportunities III Acquisition LP — Director, 10% owner Athyrium Opportunities III Acquisition 2 LP — Director, 10% owner Athyrium Opportunities 2020 LP — Director, 10% owner Ferrell Jeffrey — Director, 10% owner Athyrium Opportunities Associates Co-Invest LLC — Director, 10% owner Athyrium Funds GP Holdings LLC — Director, 10% owner Athyrium Opportunities Associates III LP — Director, 10% owner Athyrium Opportunities Associates III GP LLC — Director, 10% owner | Disposition to issuer (D) · Grant/award (A) · Disposition to issuer (D): 323,886 (derivative) · Grant/award (A): 323,886 (derivative) · Disposition to issuer (D): 500,249 (derivative) · Grant/award (A): 500,249 (derivative) · +6 more | EDGAR |
| 2024-07-08 | 4 | Athyrium Opportunities III Co-Invest 1 LP — Director, 10% owner Athyrium Opportunities III Acquisition LP — Director, 10% owner Athyrium Opportunities III Acquisition 2 LP — Director, 10% owner Athyrium Opportunities 2020 LP — Director, 10% owner Ferrell Jeffrey — Director, 10% owner Athyrium Opportunities Associates Co-Invest LLC — Director, 10% owner Athyrium Funds GP Holdings LLC — Director, 10% owner Athyrium Opportunities Associates III LP — Director, 10% owner Athyrium Opportunities Associates III GP LLC — Director, 10% owner | Grant/award (A): 457,250 (derivative) | EDGAR |
| 2024-07-05 | 4 | Athyrium Opportunities III Co-Invest 1 LP — Director, 10% owner Athyrium Opportunities III Acquisition LP — Director, 10% owner Athyrium Opportunities III Acquisition 2 LP — Director, 10% owner Athyrium Opportunities 2020 LP — Director, 10% owner Ferrell Jeffrey — Director, 10% owner Athyrium Opportunities Associates Co-Invest LLC — Director, 10% owner Athyrium Funds GP Holdings LLC — Director, 10% owner Athyrium Opportunities Associates III LP — Director, 10% owner Athyrium Opportunities Associates III GP LLC — Director, 10% owner | Grant/award (A) | EDGAR |
| 2024-06-06 | 4 | Powell Lynne — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Howe Jill Ann — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Kotzin Brian L. — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Alter Jeffrey D. — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | dEsparbes Eric — Chief Financial Officer | Grant/award (A): 325,000 @ $0 | EDGAR |
| 2024-02-15 | 4 | MOHANTY ADITYA P. — Chief Executive Officer | Grant/award (A): 819,000 @ $0 | EDGAR |
| 2024-02-15 | 4 | NEUMANN CLARKE — See Remarks | Grant/award (A): 230,000 @ $0 | EDGAR |
| 2023-12-20 | 4 | Athyrium Opportunities III Co-Invest 1 LP — Director, 10% owner Athyrium Opportunities III Acquisition LP — Director, 10% owner Athyrium Opportunities III Acquisition 2 LP — Director, 10% owner Athyrium Opportunities 2020 LP — Director, 10% owner Ferrell Jeffrey — Director, 10% owner Athyrium Opportunities Associates Co-Invest LLC — Director, 10% owner Athyrium Funds GP Holdings LLC — Director, 10% owner Athyrium Opportunities Associates III LP — Director, 10% owner Athyrium Opportunities Associates III GP LLC — Director, 10% owner | Grant/award (A): 6,953,000 (derivative) · Grant/award (A): 2,085,372 (derivative) · Disposition to issuer (D): 53,500,000 (derivative) · Grant/award (A): 10,430,000 (derivative) · Grant/award (A): 5,039,236 (derivative) | EDGAR |
| 2023-09-19 | 4 | Athyrium Opportunities III Co-Invest 1 LP — Director, 10% owner Athyrium Opportunities III Acquisition LP — Director, 10% owner Athyrium Opportunities III Acquisition 2 LP — Director, 10% owner Athyrium Opportunities 2020 LP — Director, 10% owner Ferrell Jeffrey — Director, 10% owner Athyrium Opportunities Associates Co-Invest LLC — Director, 10% owner Athyrium Funds GP Holdings LLC — Director, 10% owner Athyrium Opportunities Associates III LP — Director, 10% owner Athyrium Opportunities Associates III GP LLC — Director, 10% owner | Grant/award (A): 9,235,281 · Disposition to issuer (D): 50,000,000 (derivative) · Grant/award (A): 7,399,226 (derivative) · Grant/award (A): 16,634,507 (derivative) | EDGAR |
| 2023-08-17 | 4 | dEsparbes Eric — Chief Financial Officer | Tax withholding (F): 40,022 @ $3.14 · Grant/award (A): 219,650 @ $0 | EDGAR |
| 2023-08-17 | 4 | MOHANTY ADITYA P. — Chief Executive Officer, Director | Tax withholding (F): 117,881 @ $3.14 · Grant/award (A): 559,450 @ $0 | EDGAR |
| 2023-08-17 | 4 | NEUMANN CLARKE — See Remarks | Tax withholding (F): 36,183 @ $3.14 · Grant/award (A): 210,175 @ $0 | EDGAR |
| 2023-06-16 | 4 | Kotzin Brian L. — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Powell Lynne — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Alter Jeffrey D. — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Howe Jill Ann — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2023-05-17 | 4 | dEsparbes Eric — Chief Financial Officer | Tax withholding (F): 2,807 @ $3.35 | EDGAR |
| 2023-05-17 | 4 | MOHANTY ADITYA P. — Chief Executive Officer | Tax withholding (F): 11,249 @ $3.35 | EDGAR |
| 2023-05-17 | 4 | NEUMANN CLARKE — See Remarks | Tax withholding (F): 2,368 @ $3.35 | EDGAR |
| 2023-03-17 | 4 | MOHANTY ADITYA P. — Chief Executive Officer, Director | Grant/award (A): 155,550 @ $0 · Grant/award (A): 44,879 @ $0 · Tax withholding (F): 22,252 @ $2.56 | EDGAR |
| 2023-03-17 | 4 | dEsparbes Eric — Chief Financial Officer | Grant/award (A): 62,225 @ $0 · Grant/award (A): 22,692 @ $0 · Tax withholding (F): 11,216 @ $2.56 | EDGAR |
| 2023-03-17 | 4 | NEUMANN CLARKE — See Remarks | Grant/award (A): 57,950 @ $0 · Grant/award (A): 21,684 @ $0 · Tax withholding (F): 10,683 @ $2.56 | EDGAR |
| 2023-02-17 | 4 | dEsparbes Eric — Chief Financial Officer | Tax withholding (F): 269 @ $3.46 | EDGAR |
| 2023-02-17 | 4 | NEUMANN CLARKE — See Remarks | Tax withholding (F): 84 @ $3.46 | EDGAR |
| 2023-01-05 | 4 | Kotzin Brian L. — Director | Disposition to issuer (D): 44 | EDGAR |
| 2023-01-05 | 4 | MOHANTY ADITYA P. — Chief Executive Officer, Director | Disposition to issuer (D): 178 | EDGAR |
| 2023-01-05 | 4 | Alter Jeffrey D. — Director | Disposition to issuer (D): 65 | EDGAR |
| 2023-01-05 | 4 | Powell Lynne — Director | Disposition to issuer (D): 45 | EDGAR |
| 2023-01-05 | 4 | Sarna Surbhi — Director | Disposition to issuer (D): 8 | EDGAR |
| 2023-01-05 | 4 | dEsparbes Eric — Chief Financial Officer | Disposition to issuer (D): 95 | EDGAR |
| 2023-01-05 | 4 | Howe Jill Ann — Director | Disposition to issuer (D): 19 | EDGAR |
| 2023-01-05 | 4 | Athyrium Opportunities III Co-Invest 1 LP — 10% owner Athyrium Opportunities III Acquisition LP — 10% owner Athyrium Opportunities III Acquisition 2 LP — 10% owner Athyrium Opportunities 2020 LP — 10% owner Ferrell Jeffrey — Director, 10% owner Athyrium Opportunities Associates Co-Invest LLC — 10% owner Athyrium Funds GP Holdings LLC — 10% owner Athyrium Opportunities Associates III LP — 10% owner Athyrium Opportunities Associates III GP LLC — 10% owner | Disposition to issuer (D): 42,362 | EDGAR |
| 2023-01-05 | 4 | NEUMANN CLARKE — See Remarks | Disposition to issuer (D): 44 | EDGAR |
| 2022-11-16 | 4 | MOHANTY ADITYA P. — Chief Executive Officer, Director | Tax withholding (F): 175,071 @ $0.27 | EDGAR |
| 2022-11-16 | 4 | dEsparbes Eric — Chief Financial Officer | Tax withholding (F): 5,194 @ $0.27 | EDGAR |
| 2022-11-16 | 4 | NEUMANN CLARKE — See Remarks | Tax withholding (F): 4,529 @ $0.27 | EDGAR |
| 2022-11-14 | 4 | Athyrium Opportunities III Co-Invest 1 LP — 10% owner Athyrium Opportunities III Acquisition LP — 10% owner Athyrium Opportunities III Acquisition 2 LP — 10% owner Athyrium Opportunities 2020 LP — 10% owner Ferrell Jeffrey — Director, 10% owner Athyrium Opportunities Associates Co-Invest LLC — 10% owner Athyrium Funds GP Holdings LLC — 10% owner Athyrium Opportunities Associates III LP — 10% owner Athyrium Opportunities Associates III GP LLC — 10% owner | Purchase (P): 12,506,250 · Purchase (P): 12,506,250 (derivative) · Disposition to issuer (D): 8,097,166 (derivative) · Grant/award (A): 8,097,166 (derivative) | EDGAR |
| 2022-08-16 | 4 | dEsparbes Eric — Chief Financial Officer | Tax withholding (F): 5,952 @ $1.04 | EDGAR |
| 2022-08-16 | 4 | NEUMANN CLARKE — See Remarks | Tax withholding (F): 1,355 @ $1.04 | EDGAR |
| 2022-07-05 | 4 | Sarna Surbhi — Director | Sale (S): 7,517 @ $0.61 | EDGAR |
| 2022-06-17 | 4 | Alter Jeffrey D. — Director | Grant/award (A): 96,154 @ $0 · Grant/award (A): 148,810 (derivative) @ $0 | EDGAR |
| 2022-06-17 | 4 | Powell Lynne — Director | Grant/award (A): 96,154 @ $0 · Grant/award (A): 148,810 (derivative) @ $0 | EDGAR |
| 2022-06-17 | 4 | Sarna Surbhi — Director | Grant/award (A): 96,154 @ $0 · Grant/award (A): 148,810 (derivative) @ $0 | EDGAR |
Recent 8-K events — BIORA THERAPEUTICS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-12-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.03 — Bankruptcy or Receivership 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-10 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-11-15 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-10-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-10-11 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-10-07 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2024-09-13 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2024-09-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-08-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BIOR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs